In this podcast, our faculty discuss HER2-positive colorectal cancer. HER2 has long been associated as a biomarker and treatment target for breast cancer, but now it is also a target in some colorectal cancers. Dr. John Marshall and Dr. Sunni Kim take a look at some of the recent clinical data on the investigational therapies targeting HER2-positive colorectal cancer.

Visit http://www.MorningCommutePodcast.com/CRC2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit